Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D7MN
|
||||
Former ID |
DNC007783
|
||||
Drug Name |
Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H15NOS
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C=CC=C2C(=O)N3C4=CC=CC=C4SC5=CC=CC=C53
|
||||
InChI |
1S/C23H15NOS/c25-23(18-11-7-9-16-8-1-2-10-17(16)18)24-19-12-3-5-14-21(19)26-22-15-6-4-13-20(22)24/h1-15H
|
||||
InChIKey |
JJKRMXKTTVOCBF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.